{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:15:21Z","timestamp":1773947721930,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020611","name":"Tunku Abdul Rahman University of Management and Technology","doi-asserted-by":"publisher","award":["UC\/I\/G2019-00037"],"award-info":[{"award-number":["UC\/I\/G2019-00037"]}],"id":[{"id":"10.13039\/100020611","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bmcl.2024.129701","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T16:35:59Z","timestamp":1710261359000},"page":"129701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Synthesis and biological evaluation of hydantoin derivatives as potent antiplasmodial agents"],"prefix":"10.1016","volume":"103","author":[{"given":"Ee-Zhen","family":"Chin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1247-0814","authenticated-orcid":false,"given":"Wei-Jin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Yin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sook Yee","family":"Liew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee-Ling","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee-Ling","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohd Azlan","family":"Nafiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5861-6962","authenticated-orcid":false,"given":"Siow-Ping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.129701_b0005","unstructured":"World Health Organization. World Malaria Report 2022. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2022."},{"key":"10.1016\/j.bmcl.2024.129701_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40101-020-00251-9","article-title":"Plasmodium\u2014a brief introduction to the parasites causing human malaria and their basic biology","volume":"40","author":"Sato","year":"2021","journal-title":"J Physiol Anthropol"},{"key":"10.1016\/j.bmcl.2024.129701_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-8-268","article-title":"Environmental factors associated with the malaria vectors Anopheles gambiae and Anopheles funestus in Kenya","volume":"8","author":"Kelly-Hope","year":"2009","journal-title":"Malar J"},{"key":"10.1016\/j.bmcl.2024.129701_b0020","doi-asserted-by":"crossref","unstructured":"Ericsson, C.D. Steffen R., Stauffer W., Fischer P.R. Diagnosis and Treatment of Malaria in Children, Clin Infect Dis 2003; 37:10:1340\u20131348. https:\/\/academic.oup.com\/cid\/article\/37\/10\/1340\/451166.","DOI":"10.1086\/379074"},{"key":"10.1016\/j.bmcl.2024.129701_b0025","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/322858","article-title":"Chloroquine-resistant Malaria","volume":"184","author":"Wellems","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmcl.2024.129701_b0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/156802606776743147","article-title":"A medicinal chemistry perspective on 4-aminoquinoline Antimalarial drugs","volume":"6","author":"Neill","year":"2006","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmcl.2024.129701_b0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","article-title":"Clinically relevant drug interactions with antiepileptic drugs","volume":"61","author":"Perucca","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bmcl.2024.129701_b0040","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/33.suppl_A.23","article-title":"Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens","volume":"33","author":"Mcosker","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmcl.2024.129701_b0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1592\/phco.28.2.207","article-title":"Skeletal muscle relaxants","volume":"28","author":"See","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bmcl.2024.129701_b0050","first-page":"170","article-title":"Nilutamide a review of its Pharmacodynamic and Pharmacokinetic properties, and therapeutic efficacy in prostate cancer","volume":"3","author":"Harris","year":"1993","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bmcl.2024.129701_b0055","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1517\/13543784.9.11.2705","article-title":"Azimilide dihydrochloride: a new class III anti-arrhythmic agent","volume":"9","author":"Abrol","year":"2000","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bmcl.2024.129701_b0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0026-0495(86)90195-2","article-title":"Clinical experience with sorbinil-an aldose reductase inhibitor","volume":"35","author":"Pitts","year":"1986","journal-title":"Metabolism"},{"key":"10.1016\/j.bmcl.2024.129701_b0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1021\/ml400412x","article-title":"Evaluation of aminohydantoins as a novel class of antimalarial agents","volume":"5","author":"Meyers","year":"2014","journal-title":"ACS med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129701_b0070","first-page":"2","article-title":"Synthesis and Characterization of amino acid-derived hydantoins","volume":"23","author":"Chin","year":"2021","journal-title":"Malays J Chem"},{"key":"10.1016\/j.bmcl.2024.129701_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8866681","article-title":"In vitro antiplasmodial, heme Polymerization, and cytotoxicity of hydroxyxanthone derivatives","author":"Zakiah","year":"2021","journal-title":"J Trop Med"},{"key":"10.1016\/j.bmcl.2024.129701_b0080","unstructured":"Amit A., Bandana K. T., Rawat M. S. M. \u2018Synthesis, Antibacterial Screening and Theoretical Molecular Properties Prediction of Hydantoin-chalcone Conjugates.\u2019 2014;91:1525-1531."},{"key":"10.1016\/j.bmcl.2024.129701_b0085","doi-asserted-by":"crossref","unstructured":"Fujisaki F., Aki H., Naito A., Fukami E., Kashige N., Miake F., Sumoto K., 2014. Synthesis of New 5-Substituted Hydantoins and Symmetrical Twin-Drug Type Hydantoin Derivatives. Chem Pharm Bull 2014; 62: 5: 429-438.","DOI":"10.1248\/cpb.c14-00017"},{"key":"10.1016\/j.bmcl.2024.129701_b0090","doi-asserted-by":"crossref","unstructured":"Hidayat I., Thu Y., St. C Black D., Read R. Biological evaluation of certain substituted hydantoins and benzalhydantoins against microbes. IOP Conference Series: Mater Sci Eng, 2016;107:012058.","DOI":"10.1088\/1757-899X\/107\/1\/012058"},{"key":"10.1016\/j.bmcl.2024.129701_b0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1573406411666150708111631","article-title":"Synthesis, anticancer evaluation and docking study of 3- benzyloxyhydantoin derivatives","volume":"12","author":"Liu","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129701_b0100","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1021\/acs.jmedchem.7b00847","article-title":"Membrane-active hydantoin derivatives as antibiotic agents","volume":"60","author":"Su","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129701_b0105","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1016\/j.bmc.2017.10.045","article-title":"Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents","volume":"25","author":"Zhang","year":"2017","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2024.129701_b0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12551-021-00795-9","article-title":"Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions","volume":"29","author":"Ovung","year":"2021","journal-title":"Biophys Rev"},{"key":"10.1016\/j.bmcl.2024.129701_b0115","doi-asserted-by":"crossref","first-page":"103408","DOI":"10.1016\/j.arabjc.2021.103408","article-title":"Synthesis and antimicrobial, antiproliferative and anti-inflammatory activities of novel 1,3,5-substituted pyrazoline sulfonamides","volume":"14","author":"Thach","year":"2021","journal-title":"Arab J Chem"},{"key":"10.1016\/j.bmcl.2024.129701_b0120","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1021\/jm00022a023","article-title":"1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents","volume":"38","author":"Li","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129701_b0125","doi-asserted-by":"crossref","unstructured":"Ahmed, N.M., Lotfallah, A. H., Gaballah, M. S., Awad, S. M., Soltan, M. K. Novel 2-thiouracil-5-sulfonamide derivatives: Design, synthesis, molecular docking, and biological evaluation as antioxidants with 15-LOX inhibition. Molecules 2023; 28: 1925-1948. https:\/\/doi.org\/10.3390%2Fmolecules28041925.","DOI":"10.3390\/molecules28041925"},{"key":"10.1016\/j.bmcl.2024.129701_b0130","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/cam4.991","article-title":"Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression","volume":"6","author":"Sowa","year":"2017","journal-title":"Cancer Med"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24001033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24001033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T10:19:41Z","timestamp":1712485181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24001033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":26,"alternative-id":["S0960894X24001033"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129701","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of hydantoin derivatives as potent antiplasmodial agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"129701"}}